Mental Health, Substance Use, and Suicidal Ideation Among Unpaid Caregivers in the United States During the COVID-19 Pandemic: Relationships to Age, Race/Ethnicity, Employment, and Caregiver Intensity

Introduction

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been associated with mental health challenges related to the morbidity and mortality caused by the disease and its mitigation. Early studies have documented elevated levels of adverse mental health symptoms in the United States^1,2 and around the globe^3,4 compared with previous years. Young adults and unpaid caregivers for adults (caregivers) are among highly affected populations.

A pre-pandemic meta-analysis found that caregivers, who perform activities such as assisting others with activities of daily living and medical tasks, experienced higher levels of depression and perceived stress and lower levels of general well-being than non-caregivers.⁵ Subsequent studies have characterized an association between subjective caregiver burden and depressive symptoms,⁶ which in some cases limited provision of care.⁷

During June 2020, caregivers reported significantly higher prevalence of adverse mental and behavioural health symptoms than non-caregivers, including symptoms of an anxiety disorder, depressive disorder, or COVID-19-related trauma- and stressor-related disorder (TSRD), having started or increased substance use to cope with the pandemic, and suicidal ideation.¹ A study of 1,459 paediatric and adult brain tumour patients and 530 caregivers in 33 countries found that caregivers were significantly more anxious than patients, and 42.8% of caregivers felt that their caregiver burden has significantly increased during the pandemic.⁸

Caregivers represent a significant demographic in the United States. In 2020, the pre-pandemic estimated prevalence of caregivers was 19.2% of adults aged ≥18 years, or 47.9 million Americans.⁹ This estimate represents an increase in caregivers of more than eight million compared to 2015.¹⁰ Some people may have taken up unplanned caregiving roles during the pandemic due to mobility restrictions related to community mitigation activities designed to reduce potential exposure to SARS-CoV-2 for older adults. Moreover, others who were providing care before the pandemic may have faced barriers and disruptions to their routines and livelihood. Both scenarios require caregivers to make sacrifices to care for others during a time when their own lives may have been disrupted.

Addressing the needs of the disproportionately affected population of caregivers is critically important for the health and well-being of caregivers and the persons for whom they provide care. To effectively address these needs during the COVID-19 pandemic and afterwards, studies are needed to determine the prevalence and characteristics of caregivers, and to identify stressors that may be targets for support systems and prevention and intervention efforts. This study aims to estimate the prevalence and characteristics of US caregivers during the COVID-19 pandemic, and to evaluate factors associated with differences in mental and behavioural health symptoms.

Methods

Results

Of 9,896 eligible invited adults, 5,412 (54.7%) completed Internet-based surveys during June 24–30, 2020, including 3,638 (68.1%) first-time respondents and 1,729 (31.9%) respondents who first completed a survey for The COPE Initiative during April 2–8, 2020. Among the 5,412 respondents, 5,011 (92.6%) met secondary screening criteria and were included in this analysis (Figure 1). These 5,011 respondents included 1,362 (27.2%) caregivers and 3,649 (72.8%) non-caregivers (Table 1). There was not a significant difference in caregiver status by gender or 2019 household income, though compared to non-caregivers, caregivers were significantly more commonly of young age (e.g., 18–24 years=26.6% vs 8.0%, respectively, group p<0.0001) and either Black or Hispanic race/ethnicity (Black=18.8% vs 9.7%; Hispanic=29.0% vs 11.6%, group p<0.0001). White respondents accounted for 44.5% of caregivers and 70.8% of non-caregivers. Caregivers also more commonly reported living with a disability than not (37.9% vs 17.0%, p<0.0001), and, among employed caregivers, essential than nonessential worker status (73.7% vs 47.8%, p<0.0001) (Table 1).

• Download figure
• Open in new tab

Figure 1. Flow of Survey Respondents

Adverse mental and behavioural health symptoms were more prevalent among caregivers than non-caregivers (symptoms of anxiety or depressive disorder=57.6% vs 21.5%, respectively; symptoms of a COVID-19-related TSRD=49.0% vs 17.9%; having started or increased substance use to cope with the pandemic=35.0% vs 6.3%; suicidal ideation=33.4% vs 3.7%; at least one of these symptoms=69.6% vs 31.0%; all p<0.0001) (Tables 2,3).

Among caregivers, adverse mental and behavioural health symptoms were most prevalent among those aged 18–24 years (e.g., at least one symptom, vs those aged ≥65 years; 88.5% vs 18.8%, group p<0.0001), and were more prevalent among Black and Hispanic caregivers than White caregivers (80.2% and 89.4%, respectively, vs 53.4%, group p<0.0001) and among those with than those without disabilities (85.8% vs 59.8%, p<0.0001) (Table 2). There were also differences by employment status, as caregivers who were employed (76.1%) or students (79.0%) had higher prevalences of adverse mental and behavioural health symptoms than those who were retired (29.9%) or unemployed (59.3%) (group p<0.0001). Among employed caregivers, adverse mental and behavioural health symptoms were more common among essential than nonessential workers (81.6% vs 60.6%, p<0.0001), and were most prevalent among those who worked >60 hours in the previous week and decreased with weekly work hours (e.g., vs those who worked ≤20 hours; 96.9% vs 59.3%, group p<0.0001). There were also differences by caregiving characteristics; 93.0% of 126 caregivers providing care to multiple types of relationships reported adverse mental or behavioural health symptoms, compared with 55.6% of 261 caregivers providing care for a parent or parent-in-law (group p<0.0001). Similarly, 89.0% of 370 who had been providing care for 4–6 months, compared with 44.7% of 199 caregivers who had been providing care for more than 12 months (group p<0.0001) (Table 4). There were also difference by CII score; 91.1% of 335 caregivers with high CII scores reported at least one adverse mental or behavioural health symptom, compared with 20.7% of 31 caregivers with low CII scores (group p<0.0001).

Adjusted prevalence ratios for select demographic and caregiving variables associated with significantly different prevalences of symptoms of anxiety or depressive disorder, suicidal ideation, and at least one adverse mental or behavioural health symptom, are shown in Figure 2. Among demographic variables, adjusted prevalence of adverse mental health symptoms was higher among young caregivers aged 18–24 years vs caregivers aged 45–64 years (e.g., anxiety or depressive disorder symptoms, aPR 1.47, 95% CI 1.21–1.79, p=0.0001; suicidal ideation, 1.88, 1.26–2.82, p=0.0023; at least one of these symptoms, 1.48, 1.28–1.71, p<0.0001) and those with vs without disabilities (1.22, 1.10–1.35, p=0.0002; 2.01, 1.65–2.46, p<0.0001; 1.18, 1.10– 1.26, p<0.0001, respectively). Suicidal ideation was more prevalent among Black vs White caregivers (1.48, 1.15–1.90, p=0.0022), as was at least one of these symptoms among Hispanic vs White caregivers (1.14, 1.04–1.25, p=0.0044). Conversely, adjusted prevalence of adverse mental health symptoms was significantly lower among older adults aged ≥65 years vs caregivers aged 45–64 years (e.g., at least one adverse mental health symptom, 0.54, 0.39–0.74, p=0.0002).

• Download figure
• Open in new tab

Figure 2. Adjusted Prevalence Ratios for Having Experienced Adverse Mental or Behavioural Health Symptoms Among Unpaid Caregivers for Adults, by Select Respondent Characteristics

Among caregiving variables, adjusted prevalence of adverse mental health symptoms was higher among caregivers with ≤12 vs those with >12 months of experience (anxiety or depressive disorder symptoms, 1.24, 1.06–1.44, p=0.0059; suicidal ideation, 1.75, 1.27–2.41, p=0.0006; at least one of these symptoms, 1.25, 1.12–1.40, p=0.0001), those with >6-vs ≤6-hour weekly caregiving commitment (1.34, 1.16–1.56, p=0.0001; 1.58, 1.19–2.11, p=0.0018; 1.19, 1.07–1.31, p=0.0009, respectively), and, compared with those in the low-intensity CII group, those in the moderate-intensity (2.52, 1.61–3.94, p<0.0001; 1.92, 0.95–3.88, p=0.070; 2.30, 1.64–3.23, p<0.0001, respectively) and high-intensity (3.34, 2.12–5.26, p<0.0001; 2.91, 1.43–5.93, p=0.0034; 2.80, 1.99–3.93, p<0.0001, respectively) groups.

In the exploratory analysis of the correlation of individual CII items with adverse mental and behavioural health symptoms, the strongest average positive correlations among all adverse symptoms were observed for employment absenteeism (ρs between 0.36 and 0.46, all p<0.0001), preparedness (ρs between 0.25 and 0.45, all p <0.0001), resentment (ρs between 0.30 and 0.40, all p<0.0001), impact on expenses (ρs between 0.26 and 0.45, all p <0.0001), and family strife (ρs between 0.24 and 0.42, all p<0.0001) (Table 5). The strongest average negative correlation was observed for sense of purpose (ρs between -0.11 and -0.22, all p ≤0.0002). All correlations were in the expected direction based on their subscale categorization, except for employer support, which had a positive correlation with all adverse mental or behavioural health symptoms (ρs between 0.16 and 0.26, all p <0.0001) despite being in the Buffer subscale.

Discussion

More than one quarter (1,362 [27.2%]) of 5,011 US adult respondents identified as unpaid caregivers for adults in the three months preceding the survey in June 2020. This estimated prevalence of caregivers in the United States during the COVID-19 pandemic represents an increase over the 19.2% estimate based on data collected in 2019,⁹ which may reflect an impact of the pandemic on caregivers and recipients of care. Overall, 7 in 10 (948 of 1,362 [69.6%]) caregivers reported having experienced at least one adverse mental or behavioural health symptom. More than half of caregivers screened positive for symptoms of an anxiety or depressive disorder (785 [57.2%]), and more than one-third reported having started or increased substance use to cope with the stress or emotions related to COVID-19 (477 [35.0%]) and seriously considered suicide in the prior month (454 [33.4%]). Caregivers reported having experienced elevated levels of adverse mental and behavioural health symptoms compared to non-caregivers in this study, including three-fold increased prevalences of symptoms of anxiety or depressive disorder or a COVID-19-related TSRD, six-fold increased prevalence of having started or increased substance use to cope with the pandemic, and nine-fold increased prevalence of caregivers having seriously considered suicide compared to non-caregivers.

Both caregivers and non-caregivers who were young, Black, Hispanic, living with disabilities, essential workers, and working long hours had disproportionately high levels of adverse mental health, consistent with findings during the pandemic.^13-16 However, caregivers more commonly identified as members of these at-risk populations than non-caregivers, with more than two-thirds (928 [68.1%]) of caregivers aged below 45 years, more than half (756 [55.5%]) non-White, more than one-third living with disabilities (516 [37.9%]), and nearly three-quarters of caregivers employed as essential workers (751 of 1,018 [73.7%]), adding additional potential stressors to their caregiving responsibilities. Long work hours, which were also common among employed caregivers, are associated with increased odds of adverse health outcomes, including depression, anxiety, and impaired sleep,¹⁷ an effect that may be exacerbated by caregiving responsibilities outside of work. Committing long hours to paid work and unpaid care limits opportunities for core elements of health, including sleeping, exercising, eating, socializing, and medical care. Among caregivers, those who provide care for more hours and those who had been caregiving for fewer than 12 months had higher prevalences of adverse mental health symptoms, which may reflect stressors from being forced into a caregiving role, starting as a caregiver during the pandemic, or survival bias, whereby those who are still providing care after 12 months are more resilient to stressors associated with the role.

The findings in this report reveal that unpaid caregiving for adults is common, has likely increased during the COVID-19 pandemic, and is represented broadly across demographics. Further, the report underscores the significant impact associated with caregiving on mental and behavioural health and highlights the compounding impact of intersectionality with those who identify in multiple groups having elevated experiences of adverse mental and behavioural health. Addressing mental health among caregivers represents an urgent unmet medical need, and targeted interventions and communication strategies are needed to increase awareness of, comfort with, and access to resources for diagnosis and treatment of mental and behavioural health symptoms, especially given the time constraints faced by caregivers, many of whom are also employed. Effective communication strategies may include promoting recognition of caregivers so that they feel seen,¹⁸ addressing stigma associated with mental healthcare,^19-21 along with continuing to expand telehealth,²² which has delivered promising results in treatment for mental health conditions, including depression, substance use disorder, and suicidal ideation.²³ However, telehealth may not address all needs, with barriers to access (i.e., lack of Internet access) and limitations to provision of some care. Campaigns to increase help-seeking behaviour may also be beneficial, as caregivers more commonly avoided medical care due to concerns about COVID-19,²⁴ which may be related to their own perceived risk of SARS-CoV-2 infection, to their perceived risk and grief about potentially infecting the person for whom they are caring, or both.

The COVID-19 pandemic both introduced new challenges (e.g., barriers to in-person care provision, COVID-19 concerns) and exacerbated the challenges (e.g., financial strains) associated with caregiving that existed before the pandemic. Therefore, prevention efforts and cultural changes may be required both during and beyond the pandemic to properly address the factors associated with caregiving that contribute to elevated experiences of adverse mental health. This is of increasing importance to the economy, as even before the expected impact of COVID-19, a 2015 study estimated the value of unpaid caregiver labour to be USD$470 billion.²⁵ It is also important to note that the impact of caregiving does not end with the death of the loved ones. Pre-pandemic research highlighted that approximately 20% of bereaved caregivers experience psychiatric symptoms, including depression and/or complicated grief following the passing of their loved ones.²⁶ Given the high prevalence of employed caregivers and its compounding mental health impact, reducing the stigma that can be associated with caregiver status and establishing visible and easily accessible workplace programs should be prioritized. Employee Assistance Programs, Workplace Health Promotion Programs, personalized flexible work arrangements, and expanded options for leave that may reduce caregiving intensity if effectively utilized.²⁷ Assistive technologies may also decrease workloads required from caregivers, though may inadvertently increase the load if mismanaged or improperly designed.²⁸ Beyond these institutional changes, given the protective benefit of a caregiver’s sense of purpose and evidence that self-esteem and positive aspects of caregiving are associated with improved mental health,²⁹ creating a culture that more openly celebrates caregivers and their efforts may lead to communities of caregivers that reduce the mental health risks associated with social disconnectedness and isolation.^30-32

Strengths of this study include recruitment of a large sample of unpaid caregivers from a nationally representative sample of U.S. adults and utilization of validated screening instruments for mental health. This paper is subject limitations, which may include the following. First, unpaid caregivers for adults were self-identified, and caregiver status for children or adolescents were not assessed; future research should assess mental health among multigenerational caregivers. Second, a diagnostic evaluation for anxiety disorder or depressive disorder was not conducted; however, clinically validated screening instruments were used to assess symptoms. Third, substance use was self-reported; therefore, responses might be subject to recall, response, and social desirability biases. Fourth, the novel nature of the ARCHANGELS Caregiver Intensity Index and the specific use within this research precludes exact comparisons with normative data on caregiving intensity before the pandemic. Finally, the Internet-based survey may not be fully representative of the 2020 U.S. population and may therefore have limited generalizability. However, standardized and supplementary quality and data inclusion screening procedures were applied, and the prevalence of symptoms of anxiety disorder and depressive disorder were largely consistent with findings from the Household Pulse Survey during June.¹⁴

Further characterization of caregivers and assessment of mental health, substance use, and suicidal ideation will be required to determine the extent to which increased prevalence of caregiving and elevated adverse mental and behavioural health symptoms progress over the course of the pandemic and beyond. Investment in support systems that reflect the diverse caregiving population and improves their ability to provide care will improve societal health and well-being during this critical health crisis and beyond.

Contributors

All authors contributed to the study concept and design. MÉC, CAC, SMWR, and MEH collected the data, and MÉC conducted all analyses and wrote the first manuscript draft. All authors provided critical intellectual input and revision. SMWR and MEH provided supervision. MÉC, SMWR, and MEH had access to the underlying data.

Funding

This study was supported in part by the Institute for Breathing and Sleep, Austin Health; the Turner Institute for Brain and Mental Health, Monash University; by a gift to the Harvard Medical School and Brigham and Women’s Hospital from Philips Respironics, Inc; by a gift to Brigham and Women’s Hospital from Alexandra Drane, the CEO of ARCHANGELS; and by a contract from Whoop Inc. to Monash University. MÉC was supported by a 2020 Fulbright Future Scholarship funded by The Kinghorn Foundation through the Australian-American Fulbright Commission. CAC was supported in part by the National Institute of Occupational Safety and Health R01-OH-010300, and by an endowed professorship at Harvard Medical School funded by Cephalon, Inc.

Declaration of interests

All authors report grants from Whoop, Inc., which supported in part administration of the survey in June 2020, and other support from ARCHANGELS, which permitted the investigators to use the proprietary ARCHANGELS Caregiver Intensity Index for this study without cost. Mr Czeisler reports grants from Australian-American Fulbright Commission administered through a 2020 Fulbright Future Scholarship funded by The Kinghorn Foundation, and personal fees from Vanda Pharmaceuticals, outside the submitted work. Ms Drane is co-founder of and employed by ARCHANGELS and receives salary and has equity. Ms Drane reports grants from Ralph C Wilson Junior Foundation; personal fees from Prudential Financial Services and Walmart; and other from RAND Health, Rosalynn Carter Institute for Caregivers, United States of Care - Entrepreneurs Council, Open Notes, Executive Council for Division of Sleep Medicine – Harvard Medical School, Massachusetts Technology Collaborative, C-TAC, EndWell, Beth Israel Deaconess Medical Center, MassChallenge Health Tech, Boston Children’s Hospital, Health Evolution, Edenbridge Health, WHOOP, and HPT Development/Drane Associates, outside the submitted work. Ms Stephens Winnay reports a grant from Ralph C Wilson Junior Foundation (RCWJF), outside the submitted work. In addition, Ms Drane and Ms Winnay have a patent ARCHANGELS - Planned pending on the ARCHANGELS Caregiver Intensity Index, and a patent ARCHANGELS CII - Trademark pending on the ARCHANGELS Caregiver Intensity Index. Ms Capodilupo is employed by WHOOP, Inc., from which she receives salary and is a company shareholder, and is on the board of advisors at ARCHANGELS, and is a company shareholder. Dr Czeisler reports institutional education and research support from Cephalon, Inc. and from Philips Respironics Inc.; institutional grants from National Institute of Occupational Safety and Health R01-OH-011773; personal fees from and equity interest in Vanda Pharmaceuticals Inc; personal fees from Teva Pharmaceuticals Industries Ltd, Teva Pharma Australia, outside the submitted work. In addition, Dr Czeisler has a patent for the Actiwatch-2 and Actiwatch-Spectrum devices, with royalties paid from Philips Respironics Inc. Dr Czeisler’s interests were reviewed and managed by Brigham and Women’s Hospital and Mass General Brigham in accordance with their conflict of interest policies. Dr Czeisler served as a voluntary board member for the Institute for Experimental Psychiatry Research Foundation, Inc. Dr Shantha Rajaratnam reports grants from Turner Institute for Brain and Mental Health, Monash University; grants and personal fees from Cooperative Research Centre for Alertness, Safety and Productivity; grants and institutional consulting fees from Vanda Pharmaceuticals, and Teva Pharmaceuticals; and institutional consulting fees from BHP Billiton, Circadian Therapeutics, and Herbert Smith Freehills, outside the submitted work. Dr Mark Howard reports a grant from the Institute for Breathing and Sleep, Austin Health. No other potential competing interests were declared.